Results 21 to 30 of about 9,601 (224)

Efficacy of endoscopic cricopharyngeal myotomy using a curved rigid laryngoscope in patients with sporadic inclusion body myositis: four retrospective case reviews [PDF]

, 2023
Sporadic inclusion body myositis (s-IBM) is an acquired degenerative inflammatory myopathy that leads to slowly progressive muscle weakness and atrophy of the limbs, face, and pharynx.
Murakami, Ayuka, Sone, Michihiko, Nishio, Naoki, Maruo, Takashi, Katsuno, Masahisa, Fujimoto, Yasushi, Mukoyama, Nobuaki, Shigeyama, Mayu, Wada, Akihisa, Yokoi, Sayaka, Noda, Seiya, Tsuboi, Takashi   +11 more
core   +1 more source

Inclusion body myositis

Current Opinion in Rheumatology, 2011
Sporadic inclusion body myositis (sIBM) is a poorly understood immune and degenerative disease of skeletal muscle. Here, current opinion of the nature of this disease is summarized.Recent findings for sIBM include further characterization of muscle involvement through magnetic resonance imaging, the role of muscle as a host for immune cells, progress ...
Ivanidze, Jana, Hoffmann, Reinhard, Lochmüller, Hanns, Engel, Andrew G., Hohlfeld, Reinhard, Dornmair, Klaus   +5 more
openaire   +5 more sources

lnclusion body myositis - Genetic, clinical, and epidemiological aspects

, 2023
The inflammatory myopathy inclusion body myositis (IBM) is characterized by progressive muscle weakness and dysphagia in individuals over 45 years of age.
Lindgren, Ulrika
core   +2 more sources

Genetics in inclusion body myositis [PDF]

Current Opinion in Rheumatology, 2017
Purpose of review To review the advances in our understanding of the genetics of inclusion body myositis (IBM) in the past year. Recent findings One large genetic association study focusing on immune-related genes in IBM has refined the association within the human leukocyte antigen
Rothwell, Simon, Lilleker, James, Lamb, Janine   +2 more
openaire   +3 more sources

A Rare Case of Sporadic Inclusion Body Myositis (s-IBM) [PDF]

Journal of Clinical and Diagnostic Research, 2016
Sporadic inclusion body myositis (s-IBM) is an acquired inflammatory myopathy. Clinical presentation is variable. The usual presentation is progressive weakness and atrophy of the arms and leg muscles, especially of the quadriceps femoris which is ...
Sourya Acharya, Samarth Shukla, Pritum Kitey, Shameem Khan, SN Mahajan   +4 more
doaj   +1 more source

Sporadic inclusion body myositis in the rheumatology clinic

Indian Journal of Rheumatology, 2020
Sporadic inclusion body myositis (sIBM) is a progressive and insidious skeletal muscle disorder characterized classically by the quadriceps, wrist, and finger flexor weakness.
Fernando Henrique Carlos de Souza, Gustavo Luiz Behrens Pinto, Jean Marcos de Souza, Pablo Arturo Olivo Pallo, Leonardo Santos Hoff, Samuel Katsuyuki Shinjo   +5 more
doaj   +1 more source

Inclusion Body Myositis Treated with Alemtuzumab

European Journal of Case Reports in Internal Medicine, 2019
Inclusion body myositis (IBM) is a chronic inflammatory myopathy with a progressive course. It is more common in the later years of life and usually presents with limb weakness.
Juliana Sá, João Costelha, Antonio Marinho   +2 more
doaj   +1 more source

Dysphagia as the Presenting Symptom for Inclusion Body Myositis

Journal of Investigative Medicine High Impact Case Reports, 2021
Dysphagia can be one of the manifestations of inflammatory myopathies (IMs). In some patients, it can be one of the presenting symptoms or the only symptom.
Marcus Juan Esteban MD, Darine Kassar MD, Osvaldo Padilla MD, MPH, Richard McCallum MD   +3 more
doaj   +1 more source

Sarcoidosis and inclusion body myositis [PDF]

Rheumatology, 2008
no abstract ...
VATTEMI, Gaetano Nicola, TONIN, PAOLA, MARINI, Matteo, Guadagnin M. L., Dal Pra B., SIMONATI, Alessandro, Filosto M., TOMELLERI, Giuliano   +7 more
openaire   +3 more sources

Pembrolizumab on pre-existing inclusion body myositis: a case report

BMC Rheumatology, 2020
Background Cases of exacerbation of pre-existing neuromuscular diseases induced by immune checkpoint inhibitors (ICIs) have rarely been reported because patients with autoimmune diseases have generally been excluded from ICI therapy due to the increased ...
Naohiro Uchio, Atsushi Unuma, Toshiyuki Kakumoto, Masao Osaki, Yoshitaka Zenke, Kenichi Sakuta, Akatsuki Kubota, Yoshikazu Uesaka, Tatsushi Toda, Jun Shimizu   +9 more
doaj   +1 more source